At its July meeting, the Pharmaceutical Benefits Advisory Committee delivered a mixed result on one company's request for relief on a risk share agreement and is planning further consideration on the future of a PBS-listed COVID-19 therapy.
PBAC July outcomes a win for CF patients and AZ cancer therapies
August 21, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Eight women named finalists for 2026 Marie Krogh Young Women in Science Prize
September 17, 2026 - - Latest News -
Your success makes you a target and take it as a compliment
September 16, 2026 - -
From constitutional promise to creaking system - the PBS at 80
September 16, 2026 - - Latest News -
Young Australians badly misjudge when fertility starts to decline, new survey finds
September 16, 2026 - - Latest News -
New research points to a 'Doctor gap' holding back clinical trial participation in Australia
September 16, 2026 - - Latest News -
New Zealand ranks last among wealthy nations on modern medicines access, new report finds
September 16, 2026 - - Latest News -
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News
